GENEVA, Sept. 24 -- QUBIT PHARMACEUTICALS filed a patent application (EP2026/057520) for “NEW ACYLSULFONAMIDE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER”. With publication no. WO/2026/195684, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 231/12
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....